XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,468,911 | -9.2% | 716,303 | +2.3% | 0.01% | 0.0% |
| Q2 2023 | $26,949,423 | +4471.6% | 699,985 | +4149.8% | 0.01% | – |
| Q1 2023 | $589,497 | -90.3% | 16,471 | -91.7% | 0.00% | -100.0% |
| Q1 2022 | $6,074,000 | -33.9% | 198,701 | -32.4% | 0.00% | 0.0% |
| Q4 2021 | $9,187,000 | +5536.2% | 294,100 | +2269.9% | 0.00% | – |
| Q4 2019 | $163,000 | +71.6% | 12,410 | +17.7% | 0.00% | – |
| Q3 2019 | $95,000 | -30.7% | 10,545 | -23.9% | 0.00% | – |
| Q2 2019 | $137,000 | – | 13,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |